type 2 diabetes mellitus
Conditions
Interventions
Sancai Powder group:Sancai Powder
Control:metformin
Sponsors
the Affiliated Hospital of Chengdu University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. Patients aged between 18 to 70 years; 2. Patients to be diagnosed as type 2 diabetes mellitus; 3. Patients with BMI 18.5kg/m2 to 30kg/m2; 4. Newly diagnosed type 2 diabetes mellitus patiensts, or patients without drug for reducing blood glucose and HbA1c 7.5% to 9.5%, or patients with only 1 drug for reducing blood glucose and HbA1c 7.0% to 9.0%; 5. Patients willing to participate and sign the written informed consent.
Exclusion criteria
Exclusion criteria: 1. Type 1 diabetes mellitus; 2. Taving 2 or more kinds of drugs for reducing blood glucose level; 3. With acute complication of daibetes such as diabetic ketoacidosis, hyperosmolar nonketoti diabetic coma, hypoglecemia,etc.; 4. Complicated with heart failure, unstable angina pectoris, severe cardiac arrythmia,cardiac infarction within 12 months, SBP>180mmHg or DBP>100mmHg; 5. Complicated with liver disease such as liver cirrhosis, HBV and HCV(except carrier),or ALT or AST above 2.5 folds of normal upper limit; 6. Renal disease or clinically diagnosed renal insufficiency, SCr more than 132.6µmol/L; 7. Complicated with other endocrine disease; 8. Complicated with trauma, severe infection or undergoing surgery; 9. Complicated with mental condition, or abusing drug or alcohol; 10. Receiving steroids for treatment or chemotherapy; 11. Allergic to any drug used in this trial; 12. Women without contraception, or pregnancy during the trial; 13. Involved in other drug trial within 3 months; 14. Denied by family members.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| HbA1c;FBG;P2B; | — |
Countries
China
Contacts
Public ContactQiu Chen
Outcome results
None listed